Smart model predicts cancer patient survival from a selfie
Physicians and researchers at Mass General Brigham in the United States have developed an artificial intelligence tool capable of estimating biological age and predicting cancer patient survival rates from a single facial photograph. The innovative tool, whose results were published in The Lancet Digital Health, is based on extensive training covering more than 40 million facial images.
Burjeel and Avatrial Collaborate for AI-Driven Cancer Drug Discovery
Abu Dhabi-based Burjeel Holdings has signed a memorandum of understanding with British biotechnology company Avatrial during the Abu Dhabi Future Health Summit to explore the development of an AI-powered cancer drug discovery ecosystem. The proposed collaboration combines clinical data, multi-layered molecular analysis, and patient-derived laboratory models.